CN101018563A - 衍生自cap18的抗菌肽 - Google Patents

衍生自cap18的抗菌肽 Download PDF

Info

Publication number
CN101018563A
CN101018563A CNA2005800255122A CN200580025512A CN101018563A CN 101018563 A CN101018563 A CN 101018563A CN A2005800255122 A CNA2005800255122 A CN A2005800255122A CN 200580025512 A CN200580025512 A CN 200580025512A CN 101018563 A CN101018563 A CN 101018563A
Authority
CN
China
Prior art keywords
use according
peptide
infection
chemical compound
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800255122A
Other languages
English (en)
Chinese (zh)
Inventor
约翰内斯·雅格布斯·格罗特
扬·沃特·德费豪特
彼得·西科·西姆斯特拉
马尔特耶·约翰娜·内尔
马赛尔·扬·翁卡
吉多·文森特·布隆伯格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leids Universitair Medisch Centrum LUMC
OctoPlus Technologies BV
Original Assignee
Leids Universitair Medisch Centrum LUMC
OctoPlus Technologies BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leids Universitair Medisch Centrum LUMC, OctoPlus Technologies BV filed Critical Leids Universitair Medisch Centrum LUMC
Publication of CN101018563A publication Critical patent/CN101018563A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CNA2005800255122A 2004-07-28 2005-07-26 衍生自cap18的抗菌肽 Pending CN101018563A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04077175A EP1621205A1 (en) 2004-07-28 2004-07-28 Antimicrobial peptides derived from CAP18
EP04077175.0 2004-07-28

Publications (1)

Publication Number Publication Date
CN101018563A true CN101018563A (zh) 2007-08-15

Family

ID=34928414

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800255122A Pending CN101018563A (zh) 2004-07-28 2005-07-26 衍生自cap18的抗菌肽

Country Status (11)

Country Link
US (2) US7803756B2 (enExample)
EP (3) EP1621205A1 (enExample)
JP (1) JP2008508265A (enExample)
KR (1) KR20070050941A (enExample)
CN (1) CN101018563A (enExample)
AU (1) AU2005267651B2 (enExample)
BR (1) BRPI0513856A (enExample)
CA (1) CA2574959A1 (enExample)
NZ (1) NZ553175A (enExample)
RU (1) RU2392962C2 (enExample)
WO (1) WO2006011792A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105555290A (zh) * 2013-05-10 2016-05-04 莱顿大学学术医院以Lumc的名义运作 抗微生物肽

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1621205A1 (en) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18
EP2099466B1 (en) 2006-12-01 2015-06-03 Laclede, Inc. Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
KR20100056479A (ko) 2007-07-25 2010-05-27 바이오렉스 쎄라퓨틱스, 인코포레이티드 제어 방출 인터페론 약물 제품 및 이를 사용한 ｈｃｖ 감염의 치료
US20100184684A1 (en) * 2009-01-06 2010-07-22 C3 Jian, Inc. Antibacterial and antifungal peptides
EP3252068B1 (en) 2009-10-12 2025-07-02 Larry J. Smith Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
RU2434880C1 (ru) * 2010-07-21 2011-11-27 Общество С Ограниченной Ответственностью "Биохарт" Полипептид, имеющий антибактериальную активность и пригодный для получения лекарственных средств для лечения бактериальных инфекций человека
RU2646102C2 (ru) * 2012-05-09 2018-03-01 Контрафект Корпорейшн Предотвращение, разрушение и обработка биопленки лизином бактериофага
US9387189B2 (en) 2013-05-22 2016-07-12 Professional Compounding Centers Of America (Pcca) Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
WO2015075406A1 (en) * 2013-11-19 2015-05-28 Lipopeptide Ab New treatment of chronic ulcers
BR112016013600A2 (pt) * 2013-12-12 2017-10-03 Academisch Ziekenhuis Leiden Peptídeo antimicrobiano e seus usos
WO2015164289A1 (en) * 2014-04-21 2015-10-29 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
WO2023049162A1 (en) * 2021-09-21 2023-03-30 Biomedit, Llc Antimicrobial peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4037525B2 (ja) * 1998-03-25 2008-01-23 生化学工業株式会社 新規抗菌性ペプチド
EP1587830B1 (en) * 2003-01-28 2009-07-08 Academisch Ziekenhuis Leiden Peptide inhibitors of toxins derived from ll-37
US7718618B2 (en) * 2003-10-21 2010-05-18 The Regents Of The University Of California Human cathelicidin antimicrobial peptides
EP1621205A1 (en) * 2004-07-28 2006-02-01 OctoPlus Technologies B.V. Antimicrobial peptides derived from CAP18

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105555290A (zh) * 2013-05-10 2016-05-04 莱顿大学学术医院以Lumc的名义运作 抗微生物肽
CN105555290B (zh) * 2013-05-10 2021-11-09 莱顿大学学术医院以Lumc的名义运作 抗微生物肽

Also Published As

Publication number Publication date
EP1621205A1 (en) 2006-02-01
BRPI0513856A (pt) 2008-05-20
WO2006011792A3 (en) 2006-09-14
US20080249022A1 (en) 2008-10-09
RU2007107390A (ru) 2008-09-10
JP2008508265A (ja) 2008-03-21
KR20070050941A (ko) 2007-05-16
US20110053835A1 (en) 2011-03-03
RU2392962C2 (ru) 2010-06-27
US7803756B2 (en) 2010-09-28
AU2005267651A1 (en) 2006-02-02
AU2005267651B2 (en) 2010-05-27
NZ553175A (en) 2009-10-30
EP1784206A2 (en) 2007-05-16
EP2221061A1 (en) 2010-08-25
CA2574959A1 (en) 2006-02-02
WO2006011792A2 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
US9872885B2 (en) Antimicrobial and anti-inflammatory peptides
JP7267251B2 (ja) 抗菌組成物及び医薬組成物
KR101922409B1 (ko) 화합물들 및 그 용도
ES2264198T3 (es) Composiciones y metodos para tratar infecciones utilizando peptidos cationicos a solas o en combinacion con antibioticos.
US20110053835A1 (en) Antimicrobial peptides derived from cap18
JP2002541066A (ja) 抗微生物薬／エンドトキシンを中和するポリペプチド
US7807617B2 (en) Peptide inhibitors of toxins derived from LL-37
US20210324359A1 (en) Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditis
US7824691B2 (en) Use of RIP in treating staphylococcus aureus infections
CN115960163A (zh) 抗菌肽、包含抗菌肽的药物组合物及其应用
HK1102693A (en) Antimicrobial peptides derived from cap18
JP2022510770A (ja) 抗菌性ペプチド及びその使用方法
HK1088613B (en) Peptide inhibitors of toxins derived from ll-37

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1102693

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20070815

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1102693

Country of ref document: HK